Navigation Links
FDA Grants Charleston Laboratories, Inc. Request for Pre-IND Meeting on New Migraine Treatment
Date:4/16/2013

CHARLESTON, S.C., April 16, 2013 /PRNewswire/ -- Charleston Laboratories, Inc, an emerging specialty pharmaceutical company focused on the research and development of novel pain products that prevent or significantly reduce nausea and vomiting related to opioid analgesics and other pain associated disease states, announced today the U.S. Food and Drug Administration has granted its request for a Pre-IND meeting to discuss the proposed Investigational New Drug, CL-H1T, as a novel treatment for patients who suffer from migraine pain and migraine induced nausea or vomiting.   

"Charleston is very pleased with the response from the Neurology Products Division at FDA," said Mr. John Ameling , Vice President of Regulatory Affairs at Charleston.  "This meeting is a positive step towards the development of our novel migraine product, CL-H1T.  We look forward to discussing our proposed drug development program with FDA and initiating our clinical trials towards an approvable New Drug Application (NDA)."

"Our meeting with the agency in July is an important step in our development of CL-H1T," said Mr. Ryan Baker , Executive Vice President and Chief Operating Officer at Charleston Labs.  "After our meeting with FDA, we will be looking to enter into the best strategic partnership to successfully complete the clinical trials and support commercialization for CL-H1T to help the millions of patients suffering from migraine headaches and migraine induced nausea or vomiting."

"This milestone marks the second investigational drug in Charleston's pipeline to reach the clinic," Mr. Paul Bosse , President and Chief Executive Officer, commented.  "In addition to CL-108, which is in Phase 3 development for the treatment of acute moderate to severe pain, the development of
'/>"/>

SOURCE Charleston Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Grants Chimerix Fast Track Designation for CMX001 for the Prevention of Clinically Significant Cytomegalovirus Infection
2. Pancreatic Cancer Action Network Opposes Sequestration Cuts To National Institutes Of Health & Cancer Research Grants
3. State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
4. Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center
5. FDA Grants Orphan Drug Status To Eisais Lenvatinib
6. FDA Grants 510(k) clearance for new Fluke Biomedical ESA615 Electrical Safety Analyzer
7. U.S. FDA Grants Priority Review to Bayers Radium Ra 223 Dichloride NDA for Castration-Resistant Prostate Cancer with Bone Metastases
8. Afraxis Grants Exclusive Global License to Genentech
9. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
10. New Jersey Health Foundation Awards First Two Innovation Stage Funding Grants
11. Artemis Diagnostics awarded two grants from Technology Strategy Board to develop cancer imaging technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Today, Rhodes Pharmaceuticals L.P. announced that Aptensio ... for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will ... The announcement comes just one month ... Food and Drug Administration (FDA). ... capsule with an onset of effect of 1 ...
(Date:5/22/2015)... REDWOOD CITY, Calif. , May 22, 2015 /PRNewswire/ ... specialty pharmaceutical company focused on the development and commercialization ... breakthrough pain, today announced that interim chief executive officer ... 2015 Healthcare Conference and chief financial officer Tim ... Science Conference. Details of the two presentations are as ...
(Date:5/21/2015)... CHICAGO , May 21, 2015 /PRNewswire-USNewswire/ ... lump along the side of his neck, ... and took a couple weeks off from ... didn,t go away.                               ... Rendino, 26, was referred to Michel ...
Breaking Medicine Technology:Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... Cadence Pharmaceuticals, Inc. (NASDAQ: CADX ), a ... products principally for use in the hospital setting, today ... September 30, 2011 financial results on Thursday, November 3, ... conference call and live webcast to discuss the financial ...
... FRAMINGHAM, Mass. and SYDNEY, Oct. 27, 2011 HeartWare ... a leading innovator of less invasive, miniaturized circulatory support ... failure, announced today that David McIntyre, Chief Financial Officer ... family back to Australia for personal reasons and will ...
Cached Medicine Technology:HeartWare International Announces Planned Departure of Chief Financial Officer 2HeartWare International Announces Planned Departure of Chief Financial Officer 3HeartWare International Announces Planned Departure of Chief Financial Officer 4
(Date:5/24/2015)... May 24, 2015 The Rolling Stones ... 24th in San Diego at Petco Park. This iconic ... On May 20th, they had a warmup show in ... preview show in Los Angeles, this beloved band not only ... played fan favorites such as "Jumping Jack Flash," "Moonlight ...
(Date:5/24/2015)... Scientists with Cardno ChemRisk, a scientific consulting ... issues that may have raised the risk of mesothelioma ... posted an article on the research. Click here ... airborne asbestos levels well above OSHA safety guidelines when ... , “Asbestos compliance sampling data associated with the construction, ...
(Date:5/24/2015)... 2015 Indiana Fiber Network, LLC (IFN), ... Telecom of America, Inc. (MTA) has selected IFN as ... Childs, IFN Enterprise Sales Manager, fiber route diversity and ... fiber transport provides MTA with the diverse fiber transport ... 1 Internet and voice carriers located at Henry Street ...
(Date:5/23/2015)... 2015 On Saturday, May 23, 2015, over ... for Branches Florida City exactly five years to the day ... 2010. , A large fire tore through the Branches United ... 2010 in the middle of the night as neighbors, staff ... declared arson even though it is suspected that the fire ...
(Date:5/23/2015)... York, NY (PRWEB) May 23, 2015 ... announced that, “the company has been the target ... as a part of the company’s ongoing Information Technology ... on health insurers.” , The most notable attack ... year when Anthem Inc., the nation’s second largest health ...
Breaking Medicine News(10 mins):Health News:The Rolling Stones Tickets in San Diego, Orlando, Minneapolis, Dallas, Pittsburgh, Indianapolis, Atlanta, Detroit, Milwaukee, Kansas City, Columbus, Nashville & Raleigh 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4
... more districts in Cambodia's eastern province Kampong Cham. According to ... ,"We have discovered two more outbreaks of bird ... Phal, the director of animal health at the agriculture ministry, ... on dead duck samples taken from the two districts has ...
... the Mahim beach to drink sweet seawater for the ... drinking// the polluted water. ,Scientists clarified that ... phenomenon of dilution. ,"Dilution is a phenomenon ... the southwest monsoon and occurs when rainwater borne by ...
... Indo-American cardiologist was fired by the Cleveland Clinic for ... with a device developed by him.// Yadav is the ... used in carotid stenting procedures. Yadav was affiliated to ... of the Clinic's Innovations Foundation. ,A statement ...
... light and strong tennis rackets…. The way things ... this technology will// have its greatest influence on ... at Rush University Medical Center in Chicago think ... ovarian cancer can be developed using nanotechnology. Rush ...
... that could hold clues as to the evolution of the ... that the gene discovered has undergone a quickened evolutionary change ... brain development. The researchers have stated that though they are ... evidence they have come across seemingly suggests that it might ...
... Robert H. Lustig, pediatric endocrinologist and nationally renowned obesity ... that the obesity epidemic// is caused by a "poisoned" ... them to eat more and move less. He proposed ... Nature Clinical Practice: Endocrinology and Metabolism, after gathering results ...
Cached Medicine News:Health News:Maharashtra warns against Mahim's 'miracle' water 2Health News:Indo-American Doctor Fired By Cleveland Clinic 2Health News:Indo-American Doctor Fired By Cleveland Clinic 3Health News:Indo-American Doctor Fired By Cleveland Clinic 4Health News:Nanotechnology – to detect and treat ovarian cance 2Health News:Nanotechnology – to detect and treat ovarian cance 3Health News:A Human Brain Gene Could Hold Clues On The Evolution Of Brain Capacity 2Health News:A Human Brain Gene Could Hold Clues On The Evolution Of Brain Capacity 3Health News:A Human Brain Gene Could Hold Clues On The Evolution Of Brain Capacity 4Health News:Processed foods – "the" cause of obesity! 2Health News:Processed foods – "the" cause of obesity! 3Health News:Processed foods – "the" cause of obesity! 4
REFRESH TEARS® lubricating eye drops does more than just smoothe and relieve dry, irritated eyes. REFRESH TEARS® creates a shield of protection against further irritation with its unique, lon...
... REFRESH ENDURA™ is the first ... benefit all 3 layers of ... of moisture that lubricates and ... eyes). This helps seal in ...
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
... solution is a prescription eye drop ... to use after your cataract surgery. ... may cause them to become inflamed. ... inflammation include redness and swelling. If ...
Medicine Products: